APA

Schwartsmann G., DiLeone L. P., Horowitz M., Schunemann D., Cancella A., Pereira A. S., Richter M., Souza F., da Rocha A. B., Souza F. H., Pohlmann P. & De Nucci G. (20060901). A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. : Investigational new drugs.

Chicago

Schwartsmann G, DiLeone L P, Horowitz M, Schunemann D, Cancella A, Pereira A S, Richter M, Souza F, da Rocha A Brondani, Souza F H, Pohlmann P and De Nucci G. 20060901. A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. : Investigational new drugs.

Harvard

Schwartsmann G., DiLeone L. P., Horowitz M., Schunemann D., Cancella A., Pereira A. S., Richter M., Souza F., da Rocha A. B., Souza F. H., Pohlmann P. and De Nucci G. (20060901). A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. : Investigational new drugs.

MLA

Schwartsmann G, DiLeone L P, Horowitz M, Schunemann D, Cancella A, Pereira A S, Richter M, Souza F, da Rocha A Brondani, Souza F H, Pohlmann P and De Nucci G. A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies. : Investigational new drugs. 20060901.